Company intelligence / Profile preview

Ansep Biopharma, Inc.

Rancho Santa Fe, California, United Statesansunbiopharma.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Ansep Biopharma, Inc. is an early-stage biotechnology company incorporated in California in July 2023. It qualifies as a minority-owned and woman-owned small business focused broadly within life sciences but has yet to disclose any product pipeline details, leadership team members, clinical programs, partnerships, or proprietary platforms through major industry channels or regulatory disclosures[1][2][4]. As such, its specific therapeutic focus areas and commercial activities remain unreported at this time.

Industry: Biotech

Drug pipeline

1 asset

DAS181

Phase 2

Indications: Respiratory viral infections

Beyond the preview

Go deeper on Ansep Biopharma, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ansep Biopharma, Inc..

Explore the full profile